Institutional Repository

In vitro safety and renoprotective effects of psilocybe natalensis mushroom extracts in animal and human kidney cell lines

Show simple item record

dc.contributor.advisor Nkadimeng, Sanah M. en
dc.contributor.author Zwonaka, Mutavhatsindi
dc.date.accessioned 2026-11-09T11:37:22Z
dc.date.available 2026-11-09T11:37:22Z
dc.date.issued 2026
dc.identifier.uri https://ir.unisa.ac.za/handle/10500/33219
dc.description.abstract Background: Psilocybin containing mushrooms commonly referred to as “magic mushrooms” have been used historically for their mind healing and are increasingly being investigated for therapeutic applications, including major depressive disorder and potential anti-inflammatory properties. However, their safety and potential renoprotective effects in kidney disease remain unclear. Doxorubicin, is a widely used chemotherapeutic agent known to induce nephrotoxicity through oxidative stress, increase nitric oxide production, activate pro-inflammatory pathways and apoptosis. Aim: This study aimed to investigate the safety and morphological effects, and potential renoprotective and anti-inflammatory effects of ethanol and hot-water extracts of Psilocybe natalensis (P. natalensis) mushroom in an in vitro model of doxorubicin-induced kidney cell injury and oxidative stress on Vero monkey kidney cells and human embryonic kidney (HEK-293) cells Methods: Psilocybe natalensis “magic” mushrooms were harvested, dried, ground into a fine powder and extracted using hot-water and 70% ethanol. When confluent, Vero and HEK-293 kidney cells were treated with extracts for 48 hours to assess the cytotoxicity. Doxorubicin was used as a positive-control, and untreated cells were used as control. To test renoprotective effect, confluent Vero and HEK-293 cells were induced with 10 μM doxorubicin 45 minutes before and after treatment with different concentrations of P. natalensis water and ethanol extracts over 24 hours. Mitochondrial activity was measured using Mosmann's tetrazolium-based colorimetric (MTT) assay to assess percentage cell viability. Tumor necrosis factor-alpha (TNF-α) levels were measured in induced human HEK-293 kidney cells using ELISA. DX-10 were control cells induced with doxorubicin (10 μM); non-induced normal cells were normal cells that were neither induced nor treated with extracts; 40-DX were positive control cells that were induced and treated with 40 μM doxorubicin. Morphology on normal and doxorubicin-induced cells was assessed using phase-contrast microscopy and 100 μM lense (100x magnification). Results: The LC₅₀ values indicated that the extracts were not cytotoxic compared to doxorubicin, with LC₅₀ values below 20 μg/mL in Vero and HEK-293 kidney cells. Human HEK-293 kidney cells had lower cytotoxicity (LC₅₀ > 200 μg/mL) with both water and ethanol extracts, while Vero kidney cells had LC₅₀ of 199.50 ± 1.07 μg/mL with the ethanol extract. Doxorubicin inducing treatment (10 μM) significantly decreased percentage cell viability (p= 0.001) and increased nitrite oxide levels (p= 0.001) in both kidney cell types, with DX-40 significantly (p= 0.001) amplifying kidney cell injury effect even more. Hot-water and 70% ethanol extracts of P. natalensis enhanced %cell viability in doxorubicin-induced kidney cells in a dose-dependent manner, particularly when administered prior to doxorubicin exposure. Extracts also decreased induced-nitrite oxide levels dose-dependently, especially the 70% ethanol extract. Doxorubicin (10 μM) induced morphological changes, notably more severe in HEK-293 kidney cells. These effects of doxorubicin were not exacerbated on both kidney cells upon treatment with the mushroom extracts. Furthermore, the extracts reversed doxorubicin-induced TNF-α levels in a dose-dependent manner, with hot-water extracts showing more pronounced effects. Conclusion: The study revealed that the hot-water and 70% ethanol extracts of Psilocybe natalensis mushroom were not toxic to the normal kidney cells used in the study and especially on human kidneys cells. The extracts protected against induced-kidney cell injury and did not worsen morphological alterations in kidney cells, while they also inhibited certain pro-inflammatory markers as indicated by induced-nitric oxide levels and TNF-α levels. Notably, hot-water and 70% ethanol extracts were found to be more effective, suggesting their potential for medicinal use in preventing kidney damage. Furthermore, the study aligns with previous research that has highlighted the antioxidant and anti-inflammatory properties of this psilocybin magic mushroom species, supporting its further investigation as a potential therapeutic agent for kidney function improvement in kidney disease conditions. en
dc.format.extent 1 online resource (64 leaves) : color illustrations, color graphs en
dc.language.iso en en
dc.subject Psilocybin en
dc.subject Psilocybe natalensis en
dc.subject Doxorubicin en
dc.subject Kidney cell injury en
dc.subject Oxidative stress en
dc.subject Induced-nitric oxide en
dc.subject Nephrotoxicity en
dc.subject Renoprotective en
dc.subject Antioxidant en
dc.subject Vero cells en
dc.subject HEK-293 cells en
dc.subject Psilocybin extract en
dc.subject.lcsh Psilocybe en
dc.subject.lcsh Psilocybin -- Therapeutic use en
dc.subject.lcsh Medicinal plants -- Therapeutic use en
dc.subject.lcsh Kidneys -- Diseases -- Treatment en
dc.title In vitro safety and renoprotective effects of psilocybe natalensis mushroom extracts in animal and human kidney cell lines en
dc.type Dissertation en
dc.description.department Life and Consumer Sciences en
dc.description.degree MSc. (Life Sciences) en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search UnisaIR


Browse

My Account

Statistics